Business · 19/12/2025Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance on Bioresearch Monitoring Inspections
Summary
The FDA has issued a final guidance to comply with the Food and Drug Omnibus Reform Act of 2022, outlining processes and practices for bioresearch monitoring inspections, including record requirements and communication best practices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →